22nd Century Group, Inc. (XXII) stock forecast & analysis
0.2157
NasdaqCM · USDDelayed by 15 minutes
Down: -0.0572, -21.0%
1 analysis
Latest analysis: · verdict locked
- Open
- 0.3088
- Previous close
- 0.2729
- Day range
- 0.2025 – 0.4370
- 52-week range
- 0.2025 – 540.00
- Volume (shares)
- 111.87M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 713.99K
- P/E ratio
- Not available
- Dividend yield
- 0.00%
- Beta
- 0.72
- Market cap
- 154.01K
Market Scanner’s AI analysis of 22nd Century Group, Inc. (XXII), updated October 2026: XXII's reduced-nicotine product sales surge amid significant technical downtrend and revenue contraction.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of 22nd Century Group, Inc. (XXII) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
XXII's reduced-nicotine product sales surge amid significant technical downtrend and revenue contraction.
Recent analyses for XXII covered a sharp technical downtrend indicated by key indicators, alongside negative year-over-year quarterly revenue growth and persistent operating losses. However, the reports also noted a substantial increase in same-store unit sales for the company's reduced-nicotine products and its strategic positioning related to global nicotine-reduction initiatives.
XXII news & sentiment
News headlines highlighted positive developments regarding XXII's reduced-nicotine products, including a significant surge in unit sales and alignment with international nicotine-reduction initiatives. Social media discussions were not covered in the provided notes.
XXII technical picture
XXII's price action showed a severe downtrend, trading well below its 50-day and 200-day SMAs. Momentum indicators like RSI and MACD signaled strong selling pressure and bearish momentum, with the price falling below the lower Bollinger Band.
Fundamentals
The company's trailing twelve months revenue declined year-over-year, accompanied by negative profit and operating margins. Despite these profitability challenges, the company maintained a positive current ratio and quick ratio, with cash on hand exceeding total debt.
Factors discussed — upside
- 161% surge in same-store unit sales for Pinnacle VLN® and Pinnacle Pure products.
- Reduced-nicotine platform aligns with France's nicotine-reduction initiative.
- Company actively advocating for reduced nicotine content standards with policymakers and the FDA.
- Positive MFI reading suggesting potential capitulation buying pressure.
Factors discussed — risks
- Price significantly below 50-day and 200-day SMAs.
- Sharp declines in 7-day, 30-day, and 91-day price changes.
- RSI at 18.23, indicating strong selling pressure.
- MACD value indicates bearish momentum.
- Year-over-year quarterly revenue growth was -40.4%.
- Technical indicators
- Revenue and profitability
- Reduced-nicotine products
- Regulatory alignment
Summary updated .
XXII technical indicators
Common technical indicators for XXII, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 1.93 | Price below |
| 10-day exponential moving average | 0.47 | Price below |
| Relative strength index (14-day) | 18.19 | Oversold |
| MACD line (12/26/9) | -0.4718 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 0.13 – 1.28 | Price inside the bands |
Analyses
Recent XXII.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-10-23 XXII.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for 22nd Century Group, Inc.?
- Recent analyses highlighted a significant 161% surge in same-store unit sales for 22nd Century Group's Pinnacle VLN® and Pinnacle Pure reduced-nicotine products. The company's platform aligns with France's nicotine-reduction initiative, and it is actively advocating for reduced nicotine content standards with policymakers and the FDA. A positive Money Flow Index reading also suggested potential capitulation buying pressure.
- What are the risks for 22nd Century Group, Inc.?
- The analyses indicated a severe technical downtrend for XXII, with the price trading significantly below key moving averages and exhibiting sharp recent declines. Indicators such as the RSI and MACD pointed to strong selling pressure and bearish momentum. Furthermore, the company experienced a -40.4% year-over-year quarterly revenue decline.
- Is 22nd Century Group, Inc. bullish or bearish?
- Recent AI analyses of 22nd Century Group, Inc. examined factors on both sides. Discussed upside: Recent analyses highlighted a significant 161% surge in same-store unit sales for 22nd Century Group's Pinnacle VLN® and Pinnacle Pure reduced-nicotine products. The company's platform aligns with France's nicotine-reduction initiative, and it is actively advocating for reduced nicotine content standards with policymakers and the FDA. A positive Money Flow Index reading also suggested potential capitulation buying pressure. Discussed risks: The analyses indicated a severe technical downtrend for XXII, with the price trading significantly below key moving averages and exhibiting sharp recent declines. Indicators such as the RSI and MACD pointed to strong selling pressure and bearish momentum. Furthermore, the company experienced a -40.4% year-over-year quarterly revenue decline. These are descriptive observations, not a recommendation.
- What is the latest sentiment on 22nd Century Group, Inc.?
- News headlines highlighted positive developments regarding XXII's reduced-nicotine products, including a significant surge in unit sales and alignment with international nicotine-reduction initiatives. Social media discussions were not covered in the provided notes.
- How does Market Scanner analyse 22nd Century Group, Inc.?
- Every analysis of 22nd Century Group, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for 22nd Century Group, Inc.?
Recent analyses highlighted a significant 161% surge in same-store unit sales for 22nd Century Group's Pinnacle VLN® and Pinnacle Pure reduced-nicotine products. The company's platform aligns with France's nicotine-reduction initiative, and it is actively advocating for reduced nicotine content standards with policymakers and the FDA. A positive Money Flow Index reading also suggested potential capitulation buying pressure.
What are the risks for 22nd Century Group, Inc.?
The analyses indicated a severe technical downtrend for XXII, with the price trading significantly below key moving averages and exhibiting sharp recent declines. Indicators such as the RSI and MACD pointed to strong selling pressure and bearish momentum. Furthermore, the company experienced a -40.4% year-over-year quarterly revenue decline.
Is 22nd Century Group, Inc. bullish or bearish?
Recent AI analyses of 22nd Century Group, Inc. examined factors on both sides. Discussed upside: Recent analyses highlighted a significant 161% surge in same-store unit sales for 22nd Century Group's Pinnacle VLN® and Pinnacle Pure reduced-nicotine products. The company's platform aligns with France's nicotine-reduction initiative, and it is actively advocating for reduced nicotine content standards with policymakers and the FDA. A positive Money Flow Index reading also suggested potential capitulation buying pressure. Discussed risks: The analyses indicated a severe technical downtrend for XXII, with the price trading significantly below key moving averages and exhibiting sharp recent declines. Indicators such as the RSI and MACD pointed to strong selling pressure and bearish momentum. Furthermore, the company experienced a -40.4% year-over-year quarterly revenue decline. These are descriptive observations, not a recommendation.
What is the latest sentiment on 22nd Century Group, Inc.?
News headlines highlighted positive developments regarding XXII's reduced-nicotine products, including a significant surge in unit sales and alignment with international nicotine-reduction initiatives. Social media discussions were not covered in the provided notes.
How does Market Scanner analyse 22nd Century Group, Inc.?
Every analysis of 22nd Century Group, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh XXII.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.